Skip to content
naulon
Not checkedNot checked for notices yet.

The Association Study between Tumor Necrosis Factor- Receptor 1 36 A/G (TNFR1 36 A/G) Gene Polymorphism and Azoospermic Infertile Men in Erbil City

ashti mohammad amin said

Zanco Journal of Pure and Applied Sciences · 2021

doi:10.21271/zjpas.33.1.4 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Tumor necrosis factor-alpha (TNF-α) is a multifunctional cytokine that controls cellular activities related to spermatogenesis. (TNFR1) affects TNF- α activity and also may leads to gene dysfunction and male infertility. This retrospective study was done to assess the linkage of TNFR1 36 A/G gene polymorphism with idiopathic azoospermia in Erbil City. The present study was carried out on 98 infertile, 109 fertile males as healthy control. TNFR1 36 A/G gene polymorphisms were detected in all study subjects, and their seminal fluids were analyzed. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method is used for identify polymorphism in both cases and control groups. MspA1I restriction enzyme were digested PCR products. Digested and PCR products were analyzed by 3% gel electrophoresis for 45 minutes at 97 V.. The results of the present study showed that the incidence of AG genotype in azoospermia male higher than control groups (OR=2.069(1.154-3.708), P=0.014, this study found that G allele frequency in azoospermia men had a significant difference compared to the control group (OR=1.487 (0.992-2.170). Moreover, AG genotype and G allele associated with an increased risk of non-obstructive azoospermia in Erbil City. Downloads

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.